Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at http://www.fivestarequities.com/ and get exclusive access to our numerous stock reports.
AbbVie Inc. (NYSE: ABBV) shares declined 2.38 percent to close at $45.98 a share Tuesday. The stock traded between $45.94 and $46.95 on volume of 7.06 million shares traded. The company and Galapagos NV have recently announced plans to co-develop cystic fibrosis therapies. Shares of AbbVie have gained approximately 35.0 percent year-to-date.
Get more information on AbbVie and free access to the in-depth equity report at:
Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) shares soared 27.52 percent to close at $1.90 a share Tuesday. The stock traded between $1.55 and $2.08 on volume of 7.30 million shares traded. The company has recently announced that NEXAFED is being sold in over 2,600 pharmacies nationwide. Shares of Acura Pharmaceuticals have fallen 14.4 percent year-to-date.
Get more information on Acura Pharmaceuticals and free access to the in-depth equity report at:
EnteroMedics Inc. (NASDAQ: ETRM) shares declined 2.48 percent to close at $1.18 a share Tuesday. The stock traded between $1.07 and $1.23 on volume of 2.36 million shares traded. The company announced that the FDA has requested more information on the Maestro Rechargeable System. Shares of EnteroMedics have fallen approximately 58.0 percent year-to-date.
Get more information on EnteroMedics and free access to the in-depth equity report at:
Neogen Corporation (NASDAQ: NEOG) shares increased 2.11 percent to close at $60.97 a share Tuesday. The stock traded between $59.03 and $61.48 on volume of 75,518 shares traded. The company revenues were $58.5 million for the first quarter of fiscal 2014, an increase of 18 percent when compared to a year ago. Shares of Neogen have gained approximately 52.0 percent year-to-date.
Get more information on Neogen and free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities
Leave a comment...